A technology company specializing in the application of artificial intelligence to advance precision medicine and patient ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...

USA-based Inozyme Pharma, a biopharma developing innovative therapeutics for rare diseases that affect bone health and blood ...

New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

Swedish biotech firm PeptiSystems has joined forces with Asahi Kasei Bioprocess America in a global partnership set to ...